These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1821085)

  • 1. [Synthesis of 2,6-dimethyl-4-disubstituted phenyl-1,4-dihydropyridine-3,5-dicarboxylates as antimyocardial ischemic agents].
    Yan ZM; Dong YM
    Yao Xue Xue Bao; 1991; 26(9):661-6. PubMed ID: 1821085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety.
    Budriesi R; Bisi A; Ioan P; Rampa A; Gobbi S; Belluti F; Piazzi L; Valenti P; Chiarini A
    Bioorg Med Chem; 2005 May; 13(10):3423-30. PubMed ID: 15848754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
    Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
    Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
    Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis of alkyl 2,6-dimethyl-(substituted or unsubstituted furyl)-1,4-dihydropyridine-3,5-dicarboxylates].
    Zhang YH; Zhang ZQ; Wu Q
    Yao Xue Xue Bao; 1991; 26(5):375-8. PubMed ID: 1957689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of some 1,4-dihydropyridine derivatives and their calcium antagonistic activity.
    Safak C; Sahin I; Sunal R
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):119-22. PubMed ID: 2334450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent.
    Asano M; Uchida W; Shibasaki K; Terai M; Inagaki O; Takenaka T; Matsumoto Y; Fujikura T
    J Pharmacol Exp Ther; 1990 Jul; 254(1):204-11. PubMed ID: 1973196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and calcium antagonistic activity of a new class of 1,4-dihydropyridines having an alkoxyimino group in position 3.
    Favara D; Nicola M; Pappalardo M; Bonardi G; Luca C; Marchini F; Sardi B
    Farmaco Sci; 1987 Oct; 42(10):697-708. PubMed ID: 3436440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
    Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
    Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and X-ray crystal structure of the calcium channel antagonist: dimethyl 1,4-dihydro-2,6-dimethyl-4-[4'-(4H-4-oxo-1-benzopyran-2-yl)phenyl]- 3,5-pyridine dicarboxylate.
    Tunçbilek M; Ozbey S; Kendi E; Yildirim E; Erol K; Ertan R
    Farmaco; 1999 Oct; 54(10):660-5. PubMed ID: 10575734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers.
    Zorkun IS; Saraç S; Celebi S; Erol K
    Bioorg Med Chem; 2006 Dec; 14(24):8582-9. PubMed ID: 16971126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular tools for the study of calcium channels: synthesis and evaluation of biological activity of new derivatives of 4-aryl-1,4-dihydropyridine groups].
    Soldatov NM
    Biokhimiia; 1988 Jul; 53(7):1059-68. PubMed ID: 2846077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on condensed 1,4-dihydropyridine derivatives and their calcium modulatory activities.
    Aydin F; Safak C; Simşek R; Erol K; Ulgen M; Linden A
    Pharmazie; 2006 Aug; 61(8):655-9. PubMed ID: 16964703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of xanthone and fluorenone-1,4-dihydropyridine-5-phosphonates.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Apr; 46(4):374-7. PubMed ID: 8740081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties.
    León R; de los Ríos C; Marco-Contelles J; Huertas O; Barril X; Luque FJ; López MG; García AG; Villarroya M
    Bioorg Med Chem; 2008 Aug; 16(16):7759-69. PubMed ID: 18640842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.